19 research outputs found
PCN28 RETROSPECTIVE CLAIMS DATABASE ANALYSIS OF THE DIRECT MEDICAL COSTS ASSOCIATED WITH SORAFENIB AND SUNITINIB IN THE TREATMENT OF PATIENTS WITH RENAL CELL CARCINOMA WHO ARE UNDER 65 YEARS OLD
No full textMedical costs of sorafenib compared with sunitinib in treatment of patients <65 years with renal cell carcinoma: A retrospective claims database analysis
No full textPCN111 INFLUENCE OF AGE ON COMORBIDITIES AND TREATMENT IN PATIENTS WITH RENAL CELL CARCINOMA (RCC): A RETROSPECTIVE CLAIMS DATABASE ANALYSIS
No full textPCN110 A RETROSPECTIVE CLAIMS DATABASE COMPARISON OF SORAFENIB AND SUNITINIB DOSING PATTERNS IN PATIENTS WITH RENAL CELL CARCINOMA (RCC)
No full textDosing patterns in patients with renal cell carcinoma treated with sorafenib or sunitinib: A retrospective claims database analysis
No full textRetrospective health care claims database analysis of direct medical costs of newly diagnosed patients (pts) with hepatocellular carcinoma (HCC) in the United States.
No full text
PSK7 USING DUAN'S SMEARING ESTIMATOR TO MEASURE COST OF CHRONIC HAND DERMATITIS (CHHD) IN A MASSACHUSETTS HEALTH MAINTENANCE ORGANIZATION (HMO)
No full textPCN53 RETROSPECTIVE US CLAIMS DATABASE ANALYSIS OF THE COST OF SEQUENCING OF SORAFENIB AND SUNITINIB IN THE TREATMENT OF PATIENTS WITH RENAL CELL CARCINOMA (RCC)
No full textDose reductions and delays in patients (pts) with renal cell carcinoma (RCC) treated with sorafenib (SR) or sunitinib (SU): Retrospective analysis of two large U.S. health care claims databases.
No full text
